These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16689022)

  • 1. Lowering patient drug acquisition costs to improve health outcomes and costs.
    Mahoney JJ
    Manag Care Interface; 2006 Apr; 19(4):13. PubMed ID: 16689022
    [No Abstract]   [Full Text] [Related]  

  • 2. PDP drug costs are higher than employer plans.
    Manag Care; 2008 May; 17(5):50. PubMed ID: 18567470
    [No Abstract]   [Full Text] [Related]  

  • 3. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare?
    Moran A; Goldman L
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare overpaid dollar 110 million for part B drugs.
    Med Health; 2006 Mar; 60(13):2-3. PubMed ID: 16562555
    [No Abstract]   [Full Text] [Related]  

  • 5. PBMs agree to disclose what they pay for drugs.
    Sipkoff M
    Manag Care; 2007 Nov; 16(11):19-20. PubMed ID: 18092549
    [No Abstract]   [Full Text] [Related]  

  • 6. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.
    Sainsbury P
    Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920
    [No Abstract]   [Full Text] [Related]  

  • 7. As drug payment model changes, confusion grows among insurers.
    Sipkoff M
    Manag Care; 2007 Feb; 16(2):56-9. PubMed ID: 17361511
    [No Abstract]   [Full Text] [Related]  

  • 8. Incentives in the Medicare prescription drug benefit.
    Natl Bur Econ Res Bull Aging Health; 2006; (15):1-2. PubMed ID: 16805056
    [No Abstract]   [Full Text] [Related]  

  • 9. Unlock savings through innovative pharmacy benefit design.
    Edlin M
    AHIP Cover; 2005; 46(4):14-20. PubMed ID: 16149655
    [No Abstract]   [Full Text] [Related]  

  • 10. Merging perspectives on drug value.
    Navarro RP
    Manag Care Interface; 1998 Jan; 11(1):53-4. PubMed ID: 10178971
    [No Abstract]   [Full Text] [Related]  

  • 11. PBMs raise the curtain.
    Sipkoff M
    Manag Care; 2006 Sep; 15(9):38-40, 43. PubMed ID: 17036937
    [No Abstract]   [Full Text] [Related]  

  • 12. NHI drug costs may reach $18 billion.
    Small WE
    Am Pharm; 1980 Jan; NS20(1):17. PubMed ID: 7369114
    [No Abstract]   [Full Text] [Related]  

  • 13. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
    Hamilton C; Lokuge B; Denniss R
    Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919
    [No Abstract]   [Full Text] [Related]  

  • 14. The formulary files. PBMs report increase in drug margins.
    Manag Care; 2006 Jan; 15(1):59. PubMed ID: 16502778
    [No Abstract]   [Full Text] [Related]  

  • 15. Responses to 'bending the rules to get a medication'.
    Goddard DG
    Am Fam Physician; 2000 Jul; 62(1):44-5; author reply 46-7. PubMed ID: 10905776
    [No Abstract]   [Full Text] [Related]  

  • 16. Control your exposure for costs of injectables, biologics.
    Capitation Rates Data; 2002 Dec; 7(12):137-8. PubMed ID: 12506731
    [No Abstract]   [Full Text] [Related]  

  • 17. A sustainable future?: the role of premium subsidies in Medicare prescription drug plans.
    Demchak C
    Find Brief; 2007 Jan; 10(2):1-6. PubMed ID: 17302011
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 19. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals: state pharmaceutical assistance programs (SPAPs).
    Hilyard K; Seay M; Howe WC
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-20. PubMed ID: 17361469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.